Editorial
Published on 01 Aug 2023
Editorial: 50 years of BMT: long-term outcomes and late complications after transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1253971
- 900 views
- 2 citations
Type at least 3 characters
1,747 articles
Articles
Editorial
Published on 31 Jul 2023
Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1247808
- 1,397 views
- 2 citations
Editorial
Published on 25 Jul 2023
Editorial: Precision medicine for acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1233757
- 1,583 views
Original Research
Published on 24 Jul 2023
Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1216461
- 2,461 views
- 1 citation
Original Research
Published on 21 Jul 2023
Clinical and genetic characteristics in lymphoma patients with a second solid malignancy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1152290
- 1,867 views
- 1 citation
Original Research
Published on 21 Jul 2023
Calcineurin-independent NFATc1 signaling is essential for survival of Burkitt lymphoma cells
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1205788
- 2,871 views
Original Research
Published on 21 Jul 2023
Cigarette smoke stimulates clonal expansion of Jak2V617F and Tet2-/- cells
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1210528
- 3,404 views
- 3 citations
Original Research
Published on 20 Jul 2023
Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1193237
- 2,350 views
- 6 citations
Systematic Review
Published on 20 Jul 2023
Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1188478
- 3,134 views
- 3 citations
Original Research
Published on 18 Jul 2023
The evolution of minimal residual disease: key insights based on a bibliometric visualization analysis from 2002 to 2022
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1186198
- 4,246 views
- 2 citations
Original Research
Published on 18 Jul 2023
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1182971
- 2,254 views
- 2 citations
Review
Published on 17 Jul 2023
Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1175545
- 4,295 views
- 3 citations
Brief Research Report
Published on 17 Jul 2023
BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1196005
- 4,327 views
- 3 citations
Editorial
Published on 13 Jul 2023
Editorial: HBV and lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1236816
- 2,624 views
- 1 citation
Review
Published on 13 Jul 2023
Epigenetics in myeloproliferative neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1206965
- 3,483 views
Original Research
Published on 05 Jul 2023
Profiling of miRNAs and their interfering targets in peripheral blood mononuclear cells from patients with chronic myeloid leukaemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1173970
- 2,005 views